Jump to content

Page values for "Tiotropium"

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringTiotropium
brandStringSpiriva, Spiriva Respimat
structureFile
classesList of String, delimiter: ,[[:Category:Antimuscarinics|Antimuscarinic]] [[:Category:Long-acting_muscarinic_antagonists|Long-acting muscarinic antagonist (LAMA)]] [[:Category:Bronchodilators|Bronchodilator]]
mechanismString
usesString'"`UNIQ--vote-000009BE-QINU`"', '"`UNIQ--vote-000009BF-QINU`"'
starting_doseString18 mcg DPI once daily (HandiHaler); 2.5 mcg per actuation × 2 inhalations once daily (Respimat)
preparationsString18 mcg HandiHaler capsules; 2.5 mcg/actuation Respimat solution inhaler (1.25 mcg/actuation for asthma indication)
fda_maxStringOne dose per day
pill_idText
routesList of String, delimiter: ,Inhaled (DPI soft-mist inhaler)
onsetStringBronchodilation 30 minutes; steady-state at 1-2 weeks
durationString24 hours (long receptor dissociation half-life from M3)
halflifeString~25-44 hours plasma; receptor kinetics drive the once-daily duration'"`UNIQ--ref-000009C0-QINU`"'
bioavailabilityStringInhaled lung deposition ~20%; systemic absorption from lung ~33%; oral component negligible'"`UNIQ--ref-000009C1-QINU`"'
pregnancyStringLimited data; LABA/LAMA strategies in pregnancy generally favor agents with the most reassuring data.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup>
legalString[[USLegal:Prescription only|Rx-only]] in US